[THE EXPERTS CONSENSUS FOR ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLISM IN 2016 YR. SIGNIFICANCE OF THE RIVAROXABAN INVESTIGATIONS PROGRAM FOR CHANGES OF APPROACHES, CONCERNING TREATMENT OF THE DEEP VEINS THROMBOSIS AND PULMONARY THROMBOEMBOLISM]

Autor:	S V, Burnayeva, I I, Vasilyeva, V K, Gavrisyuk, S I, Gerasimenko, I M, Gudz, A Ya, Dzyublik, G V, Dzyak, O I, Zharinov, I I, Kobza, A A, Kovalev, E A, Kolesnik, M V, Kostylev, I V, Kulik, Ya M, Lutay, V G, Mishalov, T S, Mishchenko, A S, Nikonenko, A A, Nikonenko, P I, Nikulnikov, A N, Parkhomenko, M V, Polulyakh, K V, Rudenko, O M, Skupoy, T F, Tatarchuk, B M, Todurov, A Yu, Usenko, Yu I, Feshchenko, I M, Chernukha, A I, Yachnik
Rok vydání:	2018
Předmět:	Stroke Venous Thrombosis Consensus Rivaroxaban Neoplasms Practice Guidelines as Topic Anticoagulants Disease Management Humans Drug Dosage Calculations Venous Thromboembolism Pulmonary Embolism Drug Administration Schedule
Zdroj:	Klinichna khirurhiia. (3)
ISSN:	0023-2130
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::986d0632d366cad960ea5764c5323ec8 https://pubmed.ncbi.nlm.nih.gov/30277356 Zobrazit plný text záznamu